Price information on genetic tests is notoriously difficult to access. While this is generally true across healthcare, it is particularly challenging in genetic testing due to the variability in how test are represented by billing codes.
Concert’s unique data and systems make it possible to achieve unparalleled visibility into this space. Again this year, Concert has published price information as observed in a large, commercially insured population.
This report provides data on the top 20 categories of genetic testing, including areas such as hereditary cancer, oncology, prenatal, exome, and pharmacogenetic testing. Metrics include:
- Median price per test
- Price variability
- Price change year-over-year
- Average codes per test/claim
The goal of providing this data is to enable greater value, cost-effectiveness, and access in this critical area of precision medicine.
To access the report instantly, complete the form on this page.